Top Tweets for #ExonEditing
Thanks, @awmcconaghie and @PharmaScrip for covering our new partnership with @Roche and explaining why we believe #RNA #ExonEditing could “create therapies for conditions not amenable to existing gene therapy and gene-editing technologies.” https://t.co/zjVkytg59x
It's #LowVisionAwarenessMonth and we’re shining a light on #StargardtDisease. Want to know how and why #RNA #ExonEditing could rewrite the story of this blinding condition? Check out the video below and learn more here👇
https://t.co/oEZqdyGvQE
2/By editing exons at the RNA level, @AscidianTx’s technology enables precise editing of genes, resulting in full-length & functional proteins in the patient’s cells. Here’s a fascinating explanation of Ascidian’s unique #RNA #ExonEditing approach 👇
1/@AscidianTx - a #BioTech company developing therapies by #RNA #ExonEditing announced today that the @US_FDA has cleared its investigational new drug - IND application & granted Fast Track designation for ACDN-01 aimed to treat #StargardtDisease. #IRDs #GeneEditing #CRISPR $XBI
What’s on the schedule for the @LSXLeaders @RNALeaders USA Congress?
Our CFO & CBO, Daniel Rosan, will present on our unique approach to #ExonEditing.
There's still time to register ⏰👇https://t.co/iCOSS26nFO
Mark your calendars 🗓 for next week to hear our CMO, Jay Barth, speak at @PharmaVoice’s virtual Biotech Roundtable – diving into #TeamAscidian’s unique approach to #ExonEditing to redefine the treatment of genetically inherited diseases.
Register here 👉https://t.co/7aqYDswptv
🏌️⛳️ It was a par-ty last week for #TeamAscidian’s summer outing at the new @Puttshack in #Boston!
This approach to mini-golf pairs traditional methods with modern technology – a concept we're all too familiar with as we #RewriteRNA via #ExonEditing!
#ICYMI: Our CMO, Jay Barth, recently sat down for @FB_Canada’s “View Point” – a virtual education series sharing the latest in vision research.
Hear why he says our approach to #ExonEditing has “an advantage over traditional gene therapies” 👉https://t.co/1EGwy49ErM
We’re thrilled to announce that these talented & accomplished women are joining #TeamAscidian to help lead our development team!👏
Learn more about them & how they’ll help advance revolutionary #ExonEditing therapies for patients awaiting breakthroughs.👇
https://t.co/XEF2czJGRt
#TeamAscidian was on a roll last week celebrating our company's anniversary with a bit of #Boston flair! 🎂🎳 Now, it's back to work as we take aim to advance our #ExonEditing therapies for patients.
We’re thrilled to announce Jay Barth, MD as CMO!👏
Jay's deep & diverse expertise will make an immense impact for patients & for Ascidian as we advance our #ExonEditing therapies addressing underlying causes of disease.
Hear why he's excited to join #TeamAscidian👇
🗣️📢 It’s Ascidian’s podcast debut! Listen to our CEO discuss our unique #ExonEditing approach (#RewritingRNA), the inspiration behind our name, and his pick on where to grab lunch in Boston.
Check out the @_CellandGene podcast with @Erin_Harris1 here!👇
https://t.co/SH0WIImoRq
In this @NatureBiotech article by @Cormac_Sheridan, we highlight the possibilities of RNA editing and what makes Ascidian's #ExonEditing approach unique.
👉Shoot the messenger: RNA editing is here👇
https://t.co/W8BDZYuklk
We're diving 🏊into 2023 with our first-ever presentation at the JPM Healthcare conf. on Tues, Jan 10th! Our CEO & President, Romesh Subramanian, Ph.D, will provide an update on our company, #exonediting platform & lead program.👇
https://t.co/XEF2czJGRt
#JPM23 #RewritingRNA
As we reach the end of '22, we're reflecting on how the year started & how it's going. We've come a long way in advancing our mission to expand the potential of #RNA medicines via #ExonEditing & look forward to more to come in '23!
#TeamAscidian #RewritingRNATogether 🌊
We’ve reached the final #5 reason why our #RNA #ExonEditing platform offers meaningful advantages & expands the potential of RNA medicines for patients awaiting breakthroughs💥.
Explore all 5 here 👉 https://t.co/lV6NEsczA9
#RewritingRNA
Our second ✌ of 5 🖐 reasons why our approach to #RewritingRNA offers advantages over the current gene editing technologies includes 👇
https://t.co/lV6NEsuarH
#ExonEditing
This week, we’re sharing the 5 🖐 reasons why our approach to #rewritingRNA provides the durability and benefits of gene therapy, without the risks associated with direct DNA editing or gene replacement, starting with #1☝.
Learn more here: https://t.co/lV6NEsd7pH
#ExonEditing
TGIF🎉! Our CEO & Board Chair recently had the pleasure of talking science w/@Cormac_Sheridan. His article covers the potential of our #ExonEditing platform to #RewriteRNA & treat human disease.
We invite you to check it out 👉 https://t.co/STRS4skoyJ
We believe a rising tide 🌊 lifts all boats ⛵️ and our fantastic launch week and progress so far is due to the hard work 💪, focus 🔍, and passion 🔥 of ALL our Ascidians. Here’s to #RewritingRNA together 👏!
https://t.co/eO4zrkkTr2
#TeamAscidian #ExonEditing
📷: Kevin Trimmer
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.1M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.8M followers
Taylor Swift
@taylorswift13
83.8M followers
Lady Gaga
@ladygaga
75.3M followers
Virat Kohli
@imvkohli
73.1M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.1M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
62.9M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers